Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension

^a Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Virginia 23298, USA

Macrophages are the primary cellular targets of bacterial lipopolysaccharide (LPS), but the role of macrophage-derived cytokines in LPS-induced septic shock is uncertain. Recent evidence indicates that activation of peripheral CB1 cannabinoid receptors contributes to hemorrhagic hypotension and that macrophage-derived anandamide as well as unidentified platelet-derived substances may be contributing factors. Here we demonstrate that rat platelets contain the endogenous cannabinoid 2-arachidonyl glyceride (2-AG), as identified by reverse phase high-performance liquid chromatography, gas chromatography, and mass spectrometry, and that in vitro exposure of platelets to LPS (200 µg/ml) markedly increases 2-AG levels. LPS-stimulated, but not control, macrophages contain anandamide, which is undetectable in either control or LPS-stimulated platelets. Prolonged hypotension and tachycardia are elicited in urethane-anesthetized rats treated 1) with LPS (15 mg/kg i.v.); 2) with macrophages plus platelets isolated from 3 ml of blood from an LPS-treated donor rat; or 3) with rat macrophages or 4) platelets preincubated in vitro with LPS (200 µg/ml). In all four cases, the hypotension but not the tachycardia is prevented by pretreatment of the recipient rat with the CB1 receptor antagonist SR141716A (3 mg/kg i.v.), which also inhibits the hypotensive response to anandamide or 2-AG. The hypotension elicited by LPS-treated macrophages or platelets remains unchanged in the absence of sympathetic tone or after blockade of nitric oxide synthase. These findings indicate that platelets and macrophages generate different endogenous cannabinoids, and that both 2-AG and anandamide may be paracrine mediators of endotoxin-induced hypotension via activation of vascular CB1 receptors.—Varga, K., Wagner, J. A., Bridgen, D. T., Kunos, G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 12, 1035–1044 (1998)

Key Words: anandamide • 2-arachidonyl glyceride • CB1 cannabinoid receptors • vasodilation

This article has been cited by other articles:

				Y. Wang, M. Novotny, V. Quaiserova-Mocko, G. M. Swain, and D. H. Wang TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1517 - R1523. [Abstract] [Full Text] [PDF]

				S. Batkai, P. Mukhopadhyay, J. Harvey-White, R. Kechrid, P. Pacher, and G. Kunos Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1689 - H1695. [Abstract] [Full Text] [PDF]

				M. Bifulco, C. Grimaldi, P. Gazzerro, S. Pisanti, and A. Santoro Rimonabant: Just an Antiobesity Drug? Current Evidence on Its Pleiotropic Effects Mol. Pharmacol., June 1, 2007; 71(6): 1445 - 1456. [Abstract] [Full Text] [PDF]

				K. Benamar, M. Yondorf, J. J. Meissler, E. B. Geller, R. J. Tallarida, T. K. Eisenstein, and M. W. Adler A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1127 - 1133. [Abstract] [Full Text] [PDF]

				M. Tanaka, I. Yanagihara, H. Takahashi, M. Hamaguchi, K. Nakahira, and I. Sakata The mRNA expression of fatty acid amide hydrolase in human whole blood correlates with sepsis Innate Immunity, February 1, 2007; 13(1): 35 - 38. [Abstract] [PDF]

				S. Oka, J. Wakui, S. Ikeda, S. Yanagimoto, S. Kishimoto, M. Gokoh, M. Nasui, and T. Sugiura Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice J. Immunol., December 15, 2006; 177(12): 8796 - 8805. [Abstract] [Full Text] [PDF]

				J. Liu, L. Wang, J. Harvey-White, D. Osei-Hyiaman, R. Razdan, Q. Gong, A. C. Chan, Z. Zhou, B. X. Huang, H.-Y. Kim, et al. A biosynthetic pathway for anandamide PNAS, September 5, 2006; 103(36): 13345 - 13350. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				E. V. Gelfand and C. P. Cannon Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1919 - 1926. [Abstract] [Full Text] [PDF]

				Y.-Y. Yang, H.-C. Lin, Y.-T. Huang, T.-Y. Lee, M.-C. Hou, Y.-W. Wang, F.-Y. Lee, and S.-D. Lee Roles of anandamide in the hepatic microcirculation in cirrhotic rats Am J Physiol Gastrointest Liver Physiol, February 1, 2006; 290(2): G328 - G334. [Abstract] [Full Text] [PDF]

				H. Wahn, J. Wolf, F. Kram, S. Frantz, and J. A. Wagner The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2491 - H2496. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, D. Osei-Hyiaman, L. Offertaler, J. Liu, J. Harvey-White, A. Brassai, Z. Jarai, B. F. Cravatt, and G. Kunos Hemodynamic profile, responsiveness to anandamide, and baroreflex sensitivity of mice lacking fatty acid amide hydrolase Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H533 - H541. [Abstract] [Full Text] [PDF]

				S. Oka, S. Yanagimoto, S. Ikeda, M. Gokoh, S. Kishimoto, K. Waku, Y. Ishima, and T. Sugiura Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear J. Biol. Chem., May 6, 2005; 280(18): 18488 - 18497. [Abstract] [Full Text] [PDF]

				Y. Kadoi, H. Hinohara, F. Kunimoto, H. Kuwano, S. Saito, and F. Goto Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats Br. J. Anaesth., May 1, 2005; 94(5): 563 - 568. [Abstract] [Full Text] [PDF]

				S. M. Gardiner, J. E. March, P. A. Kemp, and T. Bennett Involvement of CB1-receptors and {beta}-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2280 - H2288. [Abstract] [Full Text] [PDF]

				K. M. Gauthier, D. V. Baewer, S. Hittner, C. J. Hillard, K. Nithipatikom, D. S. Reddy, J. R. Falck, and W. B. Campbell Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1344 - H1351. [Abstract] [Full Text] [PDF]

				S. Kishimoto, M. Muramatsu, M. Gokoh, S. Oka, K. Waku, and T. Sugiura Endogenous Cannabinoid Receptor Ligand Induces the Migration of Human Natural Killer Cells J. Biochem., February 1, 2005; 137(2): 217 - 223. [Abstract] [Full Text] [PDF]

				S. M. Gardiner, T. Bennett, G. Kunos, S. Batkai, P. Pacher, J. A. Wagner, and Z. Jarai Cannabinoids and Endotoxemia Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H451 - H451. [Abstract] [Full Text] [PDF]

				S. Oka, S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils J. Leukoc. Biol., November 1, 2004; 76(5): 1002 - 1009. [Abstract] [Full Text] [PDF]

				E. Deusch, H. G. Kress, B. Kraft, and S. A. Kozek-Langenecker The Procoagulatory Effects of Delta-9-Tetrahydrocannabinol in Human Platelets Anesth. Analg., October 1, 2004; 99(4): 1127 - 1130. [Abstract] [Full Text] [PDF]

				S. Batkai, P. Pacher, Z. Jarai, J. A. Wagner, and G. Kunos Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H595 - H600. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice J. Physiol., July 15, 2004; 558(2): 647 - 657. [Abstract] [Full Text] [PDF]

				Y. Koura, A. Ichihara, Y. Tada, Y. Kaneshiro, H. Okada, C. J. Temm, M. Hayashi, and T. Saruta Anandamide Decreases Glomerular Filtration Rate through Predominant Vasodilation of Efferent Arterioles in Rat Kidneys J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1488 - 1494. [Abstract] [Full Text] [PDF]

				S. Kishimoto, Y. Kobayashi, S. Oka, M. Gokoh, K. Waku, and T. Sugiura 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells J. Biochem., April 1, 2004; 135(4): 517 - 524. [Abstract] [Full Text] [PDF]

				J. Liu, S. Batkai, P. Pacher, J. Harvey-White, J. A. Wagner, B. F. Cravatt, B. Gao, and G. Kunos Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-{kappa}B Independently of Platelet-activating Factor J. Biol. Chem., November 7, 2003; 278(45): 45034 - 45039. [Abstract] [Full Text] [PDF]

				S. Kishimoto, M. Gokoh, S. Oka, M. Muramatsu, T. Kajiwara, K. Waku, and T. Sugiura 2-Arachidonoylglycerol Induces the Migration of HL-60 Cells Differentiated into Macrophage-like Cells and Human Peripheral Blood Monocytes through the Cannabinoid CB2 Receptor-dependent Mechanism J. Biol. Chem., June 27, 2003; 278(27): 24469 - 24475. [Abstract] [Full Text] [PDF]

				L. Offertaler, F.-M. Mo, S. Batkai, J. Liu, M. Begg, R. K. Razdan, B. R. Martin, R. D. Bukoski, and G. Kunos Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor Mol. Pharmacol., March 1, 2003; 63(3): 699 - 705. [Abstract] [Full Text] [PDF]

				R. Sancho, M. A. Calzado, V. Di Marzo, G. Appendino, and E. Munoz Anandamide Inhibits Nuclear Factor-kappa B Activation through a Cannabinoid Receptor-Independent Pathway Mol. Pharmacol., February 1, 2003; 63(2): 429 - 438. [Abstract] [Full Text] [PDF]

				M. L. Orliac, R. Peroni, S. M Celuch, and E. Adler-Graschinsky Potentiation of Anandamide Effects in Mesenteric Beds Isolated from Endotoxemic Rats J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 179 - 184. [Abstract] [Full Text] [PDF]

				J. A. Wagner, K. Hu, J. Bauersachs, J. Karcher, M. Wiesler, S. K. Goparaju, G. Kunos, and G. Ertl Endogenous cannabinoids mediate hypotension after experimental myocardial infarction J. Am. Coll. Cardiol., December 1, 2001; 38(7): 2048 - 2054. [Abstract] [Full Text] [PDF]

				E. V. BERDYSHEV, P. C. SCHMID, R. J. KREBSBACH, and H. H. O. SCHMID Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells FASEB J, October 1, 2001; 15(12): 2171 - 2178. [Abstract] [Full Text] [PDF]

				H. Iwamura, H. Suzuki, Y. Ueda, T. Kaya, and T. Inaba In Vitro and in Vivo Pharmacological Characterization of JTE-907, a Novel Selective Ligand for Cannabinoid CB2 Receptor J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 420 - 425. [Abstract] [Full Text]

				N. Garcia Jr., Z. Jarai, F. Mirshahi, G. Kunos, and A. J. Sanyal Systemic and portal hemodynamic effects of anandamide Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G14 - G20. [Abstract] [Full Text] [PDF]

				C. J. Hillard Endocannabinoids and Vascular Function J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 27 - 32. [Abstract] [Full Text]

				Z. Jarai, J. A. Wagner, S. K. Goparaju, L. Wang, R. K. Razdan, T. Sugiura, A. M. Zimmer, T. I. Bonner, A. Zimmer, and G. Kunos Cardiovascular Effects of 2-Arachidonoyl Glycerol in Anesthetized Mice Hypertension, February 1, 2000; 35(2): 679 - 684. [Abstract] [Full Text] [PDF]

				T. Sugiura, S. Kondo, S. Kishimoto, T. Miyashita, S. Nakane, T. Kodaka, Y. Suhara, H. Takayama, and K. Waku Evidence That 2-Arachidonoylglycerol but Not N-Palmitoylethanolamine or Anandamide Is the Physiological Ligand for the Cannabinoid CB2 Receptor. COMPARISON OF THE AGONISTIC ACTIVITIES OF VARIOUS CANNABINOID RECEPTOR LIGANDS IN HL-60 CELLS J. Biol. Chem., January 7, 2000; 275(1): 605 - 612. [Abstract] [Full Text] [PDF]

				L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, M. Horowitz, R. G. Pertwee, R. A. Ross, R. Mechoulam, and E. Fride HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor PNAS, December 7, 1999; 96(25): 14228 - 14233. [Abstract] [Full Text] [PDF]

				J. A. Wagner, K. Varga, Z. Jarai, and G. Kunos Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors Hypertension, January 1, 1999; 33(1): 429 - 434. [Abstract] [Full Text] [PDF]